ATE424186T1 - Medizinische aerosolzusammensetzungen mit einem funktionalisierten polyethylenglykol-hilfsstoff - Google Patents
Medizinische aerosolzusammensetzungen mit einem funktionalisierten polyethylenglykol-hilfsstoffInfo
- Publication number
- ATE424186T1 ATE424186T1 AT02806511T AT02806511T ATE424186T1 AT E424186 T1 ATE424186 T1 AT E424186T1 AT 02806511 T AT02806511 T AT 02806511T AT 02806511 T AT02806511 T AT 02806511T AT E424186 T1 ATE424186 T1 AT E424186T1
- Authority
- AT
- Austria
- Prior art keywords
- polyethylene glycol
- compositions containing
- excipient
- aerosol compositions
- functionalized polyethylene
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/541—Organic ions forming an ion pair complex with the pharmacologically or therapeutically active agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Otolaryngology (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34278701P | 2001-12-21 | 2001-12-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE424186T1 true ATE424186T1 (de) | 2009-03-15 |
Family
ID=23343270
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02806511T ATE424186T1 (de) | 2001-12-21 | 2002-12-20 | Medizinische aerosolzusammensetzungen mit einem funktionalisierten polyethylenglykol-hilfsstoff |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US7718162B2 (enExample) |
| EP (1) | EP1458357B1 (enExample) |
| JP (1) | JP4959919B2 (enExample) |
| AT (1) | ATE424186T1 (enExample) |
| AU (1) | AU2002367032B8 (enExample) |
| CA (1) | CA2470520A1 (enExample) |
| DE (1) | DE60231428D1 (enExample) |
| WO (1) | WO2003059317A2 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1458357B1 (en) | 2001-12-21 | 2009-03-04 | 3M Innovative Properties Company | Medicinal aerosol compositions with a functionalized polyethyleneglycol excipient |
| EP1458354A1 (en) * | 2001-12-21 | 2004-09-22 | 3M Innovative Properties Company | Medicinal aerosol formulations comprising ion pair complexes |
| CA2470498A1 (en) * | 2001-12-21 | 2003-07-24 | 3M Innovative Properties Company | Medicinal aerosol compositions with an amide and/or ester containing excipient compound |
| GB0614621D0 (en) | 2006-07-24 | 2006-08-30 | 3M Innovative Properties Co | Metered dose dispensers |
| GB0620700D0 (en) | 2006-10-19 | 2006-11-29 | 3M Innovative Properties Co | Metered dose valves and dispensers |
| NZ599344A (en) | 2009-09-25 | 2015-02-27 | Reddy’S Lab Ltd Dr | Formulations comprising triptan compounds |
| US11337962B2 (en) | 2009-09-25 | 2022-05-24 | Upsher-Smith Laboratories, Llc | Formulations comprising triptan compounds |
| US20120272951A1 (en) | 2009-12-16 | 2012-11-01 | 3M Innovative Properties Company | Formulations and methods for controlling mdi particle size delivery |
| GB201118188D0 (en) | 2011-10-21 | 2011-12-07 | 3M Innovative Properties Co | Manufacture of medicinal aerosol canisters |
| GB201210580D0 (en) | 2012-06-14 | 2012-08-01 | 3M Innovative Properties Co | Metered dose dispensing valve |
| GB201221063D0 (en) | 2012-11-23 | 2013-01-09 | 3M Innovative Properties Co | Metered dose dispensing valve |
| EP3649175A1 (en) | 2017-07-07 | 2020-05-13 | Basf Se | Alkoxylated esteramines and salts thereof |
| CN117042803A (zh) * | 2021-12-02 | 2023-11-10 | 丽泽润有限公司 | 具有多功能应用的天然赋形剂及其制备方法 |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1163028B (de) * | 1960-03-09 | 1964-02-13 | Hoechst Ag | Verfahren zur Polymerisation von Vinylchlorid |
| ATE71520T1 (de) * | 1986-03-10 | 1992-02-15 | Burghart Kurt | Pharmazeutische zubereitung sowie verfahren zur herstellung derselben. |
| JP2573275B2 (ja) * | 1986-03-10 | 1997-01-22 | ブルグハルト，クルト | 薬学的製剤及びその製造法 |
| US5225183A (en) * | 1988-12-06 | 1993-07-06 | Riker Laboratories, Inc. | Medicinal aerosol formulations |
| US5342940A (en) * | 1989-05-27 | 1994-08-30 | Sumitomo Pharmaceuticals Company, Limited | Polyethylene glycol derivatives, process for preparing the same |
| JP2854974B2 (ja) * | 1990-06-29 | 1999-02-10 | フアイソンズ・ピーエルシー | 加圧エアロゾル組成物 |
| WO1994008599A1 (en) * | 1992-10-14 | 1994-04-28 | The Regents Of The University Of Colorado | Ion-pairing of drugs for improved efficacy and delivery |
| ES2129117T3 (es) | 1992-12-09 | 1999-06-01 | Boehringer Ingelheim Pharma | Formulaciones en disolucion en forma de aerosol medicinales estabilizadas. |
| KR100321649B1 (ko) * | 1993-03-17 | 2002-07-22 | 미네소타 마이닝 앤드 매뉴팩춰링 캄파니 | 에스테르,아미드또는머캅토에스테르로부터유도된분산보조제를함유하는에어로졸제제 |
| DE69405719T2 (de) * | 1993-03-17 | 1998-01-15 | Minnesota Mining & Mfg | Aerosolzubereitung, enthaltend ein aus einem diol-disäure-derivat abgeleitetes dispergiermittel |
| US5492688A (en) * | 1993-04-28 | 1996-02-20 | The Center For Innovative Technology | Metered dose inhaler fomulations which include the ozone-friendly propellant HFC 134a and a pharmaceutically acceptable suspending, solubilizing, wetting, emulsifying or lubricating agent |
| JPH09506097A (ja) * | 1993-12-02 | 1997-06-17 | アボツト・ラボラトリーズ | 非ｃｆｃ噴射剤と共に用いるエアロゾル薬物調剤 |
| US5508023A (en) * | 1994-04-11 | 1996-04-16 | The Center For Innovative Technology | Pharmaceutically acceptable agents for solubilizing, wetting, emulsifying, or lubricating in metered dose inhaler formulations which use HFC-227 propellant |
| US6524557B1 (en) | 1994-12-22 | 2003-02-25 | Astrazeneca Ab | Aerosol formulations of peptides and proteins |
| ZA9711732B (en) * | 1996-12-31 | 1998-12-28 | Quadrant Holdings Cambridge | Methods and compositions for improvement bioavailability of bioactive agents for mucosal delivery |
| US6126919A (en) * | 1997-02-07 | 2000-10-03 | 3M Innovative Properties Company | Biocompatible compounds for pharmaceutical drug delivery systems |
| US6218353B1 (en) * | 1997-08-27 | 2001-04-17 | Micell Technologies, Inc. | Solid particulate propellant systems and aerosol containers employing the same |
| US6136294C1 (en) * | 1998-09-22 | 2002-09-24 | Aeropharm Technology Inc | Amino acid stabilized medical aerosol formulation |
| BR9914799A (pt) * | 1998-10-27 | 2001-07-10 | Alcon Lab Inc | Sistema conservante para composições farmacêuticas administráveis topicamente contendo um sabão de ácido graxo/aminoácido |
| US6258857B1 (en) * | 1999-02-04 | 2001-07-10 | Kyowa Industrial Co., Ltd. | Internal liquid composition contained as internal liquid in a releasing container and releasing container product |
| GB0016876D0 (en) | 2000-07-11 | 2000-08-30 | Astrazeneca Ab | Novel formulation |
| JP2004509159A (ja) | 2000-09-22 | 2004-03-25 | グラクソ グループ リミテッド | 新規なアルカン酸誘導体 |
| KR20030097876A (ko) | 2001-05-21 | 2003-12-31 | 넥타르 테라퓨틱스 | 화학적으로 개질된 인슐린의 폐 투여 |
| GB0125127D0 (en) | 2001-10-19 | 2001-12-12 | Glaxo Group Ltd | Compounds |
| CA2470498A1 (en) * | 2001-12-21 | 2003-07-24 | 3M Innovative Properties Company | Medicinal aerosol compositions with an amide and/or ester containing excipient compound |
| EP1458357B1 (en) | 2001-12-21 | 2009-03-04 | 3M Innovative Properties Company | Medicinal aerosol compositions with a functionalized polyethyleneglycol excipient |
-
2002
- 2002-12-20 EP EP02806511A patent/EP1458357B1/en not_active Expired - Lifetime
- 2002-12-20 CA CA002470520A patent/CA2470520A1/en not_active Abandoned
- 2002-12-20 AT AT02806511T patent/ATE424186T1/de not_active IP Right Cessation
- 2002-12-20 AU AU2002367032A patent/AU2002367032B8/en not_active Ceased
- 2002-12-20 US US10/327,200 patent/US7718162B2/en not_active Expired - Fee Related
- 2002-12-20 WO PCT/US2002/041299 patent/WO2003059317A2/en not_active Ceased
- 2002-12-20 DE DE60231428T patent/DE60231428D1/de not_active Expired - Lifetime
- 2002-12-20 JP JP2003559480A patent/JP4959919B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003059317A2 (en) | 2003-07-24 |
| AU2002367032A1 (en) | 2003-07-30 |
| CA2470520A1 (en) | 2003-07-24 |
| EP1458357A2 (en) | 2004-09-22 |
| DE60231428D1 (de) | 2009-04-16 |
| WO2003059317A3 (en) | 2003-11-20 |
| JP4959919B2 (ja) | 2012-06-27 |
| AU2002367032B2 (en) | 2008-09-25 |
| US7718162B2 (en) | 2010-05-18 |
| JP2006502086A (ja) | 2006-01-19 |
| EP1458357B1 (en) | 2009-03-04 |
| AU2002367032B8 (en) | 2008-10-23 |
| US20030152521A1 (en) | 2003-08-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200401006A1 (ru) | Аэрозольные препараты для внутрилёгочного введения лекарств с получением системного действия | |
| BR9909394A (pt) | Composição de aerossol, composição farmacêutica, recipiente, dispositivo de inalação, processo para preparar uma composição de aerossol, mistura de um primeiro material particulado, e, processo para administrar um medicamento particulado | |
| DE60231428D1 (de) | Medizinische aerosolzusammensetzungen mit einem funktionalisierten polyethylenglykol-hilfsstoff | |
| BR0214254A (pt) | Pó filmogênio micronizado e composição farmacêutica, cosmética ou neutracêutica | |
| DE60102971D1 (de) | Pulverisiertes Mannit und Verfahren zu deren Herstellung | |
| ATE287699T1 (de) | Pharmazeutische aerosolzusammensetzungen | |
| DE69932835D1 (de) | Medizinische aerosolzubereitung | |
| ATE271383T1 (de) | Pulverformulierung zur inhalation | |
| BG105189A (bg) | Капсула от две части за пълнене с фармацевтични препарати за прахови инхалатори | |
| FI956228A0 (fi) | Sisäänhengitykseen tarkoitettuja koostumuksia | |
| WO1995017156A3 (en) | Ethanol substitutes | |
| ES2193186T3 (es) | Composiciones medicamentosas en aerosol para la utilizacion con gases propulsores sin cfc. | |
| ATE364381T1 (de) | Formulierungen zur verwendung in inhalationsvorrichtungen | |
| CA2416403A1 (en) | A medicinal aerosol formulation | |
| HUP9802454A2 (hu) | Inhalálókészülék | |
| EP1757269A3 (en) | Pulmonary formulation comprising silicon particles | |
| DE60137452D1 (de) | Pulverzubereitungen und verfahren zu ihrer herstellung | |
| HUP9802391A2 (hu) | Inhaláló berendezés szalmeterol adagolására mért dózisban | |
| ATE321537T1 (de) | Pharmazeutische zubereitung enthaltend doxazosin | |
| ATE230980T1 (de) | Formulierungen mit verzögerter freisetzung zur abgabe von metoprolol über 24 stunden | |
| DE69233150D1 (de) | Fluorchlorkohlenwasserstoffreie Aerosolformulierungen | |
| WO2003075977A3 (en) | Agglomerated particles for aerosol drug delivery | |
| ATE406152T1 (de) | Medizinische aerosolzusammensetzungen mit einer eine amid- und/oder estergruppe enthaltenden exzipientenverbindung | |
| CA2423574A1 (en) | Stabilization of solid drug formulations | |
| EA200000664A1 (ru) | Фармацевтические композиции, содержащие микронизированные бициклические лекарственные средства |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |